Prognostic factors and new therapeutic approaches to cervical cancer

Author： Stanley M.A.  

Publisher： Elsevier

ISSN： 0168-1702

Source： Virus Research, Vol.89, Iss.2, 2002-11, pp. : 241-248

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The viral etiology of cervical cancer

By Bosch F.X.   Munoz N.  

Virus Research, Vol. 89, Iss. 2, 2002-11 ,pp. : 183-190

Elsevier

Access to resources Recommend Favorite

Mitochondrial damage by a new antitumour agent furanonaphthoquinone derivative in human cervical cancer HeLa cells

By Koyama J.  

Journal of Electron Microscopy, Vol. 46, Iss. 2, 1997-01 ,pp. : 181-187

Oxford University Press

Access to resources Recommend Favorite

Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients

By Ravaggi A.   Romani C.   Pasinetti B.   Tassi R. A.   Bignotti E.   Bandiera E.   Odicino F. E.   Ragnoli M.   Donzelli C.   Falchetti M.   Calza S.   Santin A. D.   Pecorelli S.  

Archives of Virology, Vol. 151, Iss. 10, 2006-10 ,pp. : 1899-1916

Springer Publishing Company

Access to resources Recommend Favorite

Evidence-based medicine applied to cervical cancer

By Kitchener H.  

Virus Research, Vol. 89, Iss. 2, 2002-11 ,pp. : 175-181

Elsevier

Access to resources Recommend Favorite

Health economics and cervical cancer prevention: a global perspective

By Goldie S.J.  

Virus Research, Vol. 89, Iss. 2, 2002-11 ,pp. : 301-309

Elsevier

Access to resources Recommend Favorite